Project case study

Pharmaceutical Development Facility for AstraZeneca, UK

Science and technology

An energy efficient development facility

  • 20% energy cost savings
  • 25% reduction in on-site construction time
  • Whole-life savings of £4 million
  • Multi-purpose flexible design to reduce footprint
Client

AstraZeneca

Value
£63 million

AstraZeneca needed flexible research and development laboratories which keep pace with changing scientific needs. This drove the ethos of AstraZeneca’s new £63 million Pharmaceutical Development Facility at Macclesfield, the largest single capital investment approved on the site. Advanced modular construction techniques were used in the delivery of building services ‘future-proofing’ the laboratory space.

Over 220 scientists and office staff work in the 12,000m2 four-floor building, The ground floor provides the main meeting rooms and business support functions with a central service hub linked to each of the three laboratory floors.

“We reduced energy costs for Astra Zeneca by 20% and were able to knock six months off the construction programme time by building 80% of the facility off site”